Asian-Pacific Islander race independently predicts poor outcome in patients with endometrial cancer

Gynecologic Oncology

Volumn 89, Issue 2, 2003, Pages 218-226

  Kost, Edward R ^a   Hall, Kevin L ^a   Hines, Jeffrey F ^b   Farley, John H ^c   Nycum, Lawrence R ^d   Rose, G Scott ^e   Carlson, Jay W ^e   Fischer Jr , Joseph R ^f   Kendall, Brian S ^g  

^a BROOKE ARMY MEDICAL CENTER   (United States)

^b Southeastern Gynecologic Oncology LLC   (United States)

^c TRIPLER ARMY MEDICAL CENTER   (United States)

^d DAVID GRANT MEDICAL CENTER   (United States)

^e WALTER REED ARMY MEDICAL CENTER   (United States)

^f Wellford Hall Medical Center ^*  (United States)

^g Building 3600 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; ARMY; ARTICLE; ASIAN; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER SURGERY; CANCER SURVIVAL; CAUCASIAN; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MEDICAL INFORMATION SYSTEM; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEGRO; PACIFIC ISLANDS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; REGISTER; STATISTICAL SIGNIFICANCE; SURVIVAL TIME;

EID: 0037404827     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(03)00050-7     Document Type: Article

References (41)

1. Greenlee R.T., Hill-Harmon M.B., Murray T., Thun M. Cancer statistics, 2001. CA Cancer J Clin. 51:2001;15-36.
2. Liu R.J., Conaway M., Rodriguez G.C., Soper J.T., Clarke-Pearson D.L., Berchuck A. Relationship between race and interval to treatment in endometrial cancer. Obstet Gynecol. 86:1995;486-490.
3. Hill H.A., Eley J.W., Harlan L.C., Greenberg R.S., Barrett R.J., Chen V.W. Racial differences in endometrial cancer survival the black/white cancer survival study . Obstet Gynecol. 88:1996;919-926.
4. Aziz H., Hussian F., Edelman S., Cirrone J., Aral I., Fruchter R., et al. Age and race as prognostic factors in endometrial carcinoma. Am J Clin Oncol. 19:1996;595-600.
5. Hicks M.L., Kim W., Abrams J., Johnson C.C., Blount A.C., Parham G.P. Racial differences in surgically staged patients with endometrial cancer. J Natl Med Assoc. 89:1997;134-140.
6. Matthews R.P., Hutchinson-Colas J., Maiman M., Fruchter R.G., Gates E.J., Gibbon D., et al. Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women. Gynecol Oncol. 65:1997;206-212.
7. Hicks M.L., Phillips J.L., Groesbeck P., Andrews N., Jones W.B., Shingleton H.M., et al. The national cancer database report on endometrial carcinoma in African-American women. Cancer. 83:1998;2629-2637.
8. Connell P.P., Rotmensch J., Waggoner S.E., Mundt A.J. Race and clinical outcome in endometrial carcinoma. Obstet Gynecol. 94:1999;713-720.
9. Kitano HHL, Daniels R. Asian American: emerging minorities. Englewood Cliffs, NJ: Prentice-Hall, 1995.
10. Tu S.P., Taplin S.H., Barlow W.E., Boyko E.J. Breast cancer screening by Asian-American women in a managed care environment. Am J Prev Med. 17:1999;55-61.
11. Robison S.W., Dietrich C.S., Person D.A., Farley J.H. Ethnic differences in survival among pacific island patients diagnosed with cervical cancer. Gynecol Oncol. 84:2002;303-308.
12. Maskarinec G., Wilkens L. Ethnic differences and factors related to breast cancer survival in Hawaii. Int J Epidemiol. 26:1997;1151-1158.
13. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK, editors. SEER cancer statistics review, 1973-1997. Bethesda, MD: National Cancer Institute, 2000.
14. Annual report of the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 20:1988;75-77.
15. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc. 53:1958;457-481.
16. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 50:1966;163-170.
17. Maxwell G.L., Risinger J.I., Hayes K., Alvarez A.A., Dodge R.K., Barrett J.C., et al. Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers. Clin Cancer Res. 6:2000;2999-3005.
18. Hill H.A., Coates R.J., Austin H., Correa P., Robboy S.J., Chen V., et al. Racial differences in tumor grade among women with endometrial cancer. Gynecol Oncol. 56:1995;154-163.
19. Connelly P., Alberhasky R., Christopherson W. Carcinoma of the endometrium. III. Analysis of 865 cases of adenocarcinoma and adenoacanthoma. Obstet Gynecol. 59:1982;569-575.
20. Farley J.H., Nycum L.R., Birrer M.J., Park R.C., Taylor R.R. Age-specific survival of women with endometriod adenocarcinoma of the uterus. Gynecol Oncol. 79:2000;86-89.
21. Lukes A.S., Kohler M.F., Pieper C.F., Kerns B.J., Bently R., Rodriguez G.C., et al. Multivariate analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer. Cancer. 73:1994;2380-2385.
22. Podratz K.C., Wilson T.O., Gaffey T.A., Cha S.S., Katzmann J.A. Deoxyribonucleic acid analysis facilitates the pretreatment identification of high-risk endometrial cancer patients. Am J Obstet Gynecol. 168:1993;1206-1215.
23. Kohler M.F., Carney P., Dodge R., Soper J.T., Clark-Pearson D.L., et al. P53 overexpression in advanced-stage endometrial cancer. Am J Obstet Gynecol. 175:1996;1246-1252.
24. Risinger J.I., Hayes K., Maxwell G.L., Carney M.E., Dodge R.K., Barrett J.C., et al. PTEN mutations in endometrial cancers is associated with favorable clinical and pathologic characteristics. Clin Cancer Res. 4:1998;3005-3010.
25. Hetzel D.J., Wilson T.O., Keeney G.L., Roche P.C., Cha S.S., Podratz K.C. HER-2/neu expression a major prognostic factor in endometrial cancer . Gynecol Oncol. 47:1992;179-185.
26. Leiserowitz G.S., Harris S.A., Subramaniam M., Keeney G.L., Podratz K.C., Spelsberg T.C. The proto-oncogene c-fms is overexpressed in endometrial cancer. Gynecol Oncol. 49:1993;190-196.
27. Schwartzbaum J.A., Hulka B.S., Fowler W.C., Kaufman D.G., Hoberman D. The influence of exogenous estrogen use on survival after diagnosis of endometrial cancer. Am J Epidemiol. 126:1987;851-860.
28. Plaxe S.C., Saltzstein S.L. Impact of ethnicity on the incidence of high-risk endometrial cancer. Gynecol Oncol. 65:1997;8-12.
29. Howard J., Hankey B.F., Greenberg R.S., Austin D.F., Correa P., Chen V.W., et al. A collaborative study of differences in the survival rates of black patients and white patients with cancer. Cancer. 69:1992;2349-2360.
30. McGuire V., Jesser C.A., Whittemeore A.S. Survival among U.S. women with invasive epithelial ovarian cancer. Gynecol Oncol. 84:2002;399-403.
31. Oriel K.A., Hartenbach E.M., Remington P.L. Trends in United States ovarian cancer mortality, 1979-1995. Obstet Gynecol. 93:1999;30-33.
32. Parham G., Phillips J.L., Hicks M.L., Andrews N., Jones W.B., Shingleton H.M., et al. The national cancer database report on malignant epithelial ovarian carcinoma in African-American women. Cancer. 80:1997;816-826.
33. Bach P.B., Cramer L.D., Warren J.L., Begg C.B. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 341:1999;1198-1205.
34. Powell B., Soong R., Grieu F., Hammond I., Iacopetta B. p53 protein overexpression is a prognostic indicator of poor survival in stage I endometrial carcinoma. Int J Oncol. 14:1999;175-179.
35. Kohlberger P., Gitsch G., Loesch A., Tempfer C., Kaider A., Reinthaller A., et al. p53 protein overexpression in early stage endometrial cancer. Gynecol Oncol. 62:1996;213-217.
36. Clifford S.L., Kaminetsky C.P., Cirisano F.D., Dodge R., Soper J.T., Clarke-Pearson D.L., et al. Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancer. Am J Obstet Gynecol. 176:1997;229S-232S.
37. Ito K., Watanabe K., Nasim S., Sasano H., Sato S., Yajima A., et al. Prognostic significance of p53 overexpression in endometrial cancer. Cancer Res. 54:1994;4667-4670.
38. Inoue M., Okayama A., Fujita M., Enomoto T., Sakata M., Tanizawa O., Ueshima H. Clinico pathologic characteristics of p53 overexpression in endometrial cancers. Int J Cancer. 58:1994;14-19.
39. Hedeen A.N., White E., Taylor V. Ethnicity and birthplace in relation to tumor size and stage in Asian American women with breast cancer. Am J Public Health. 89:1999;1248-1252.
40. Matsunaga D.S., Enos R., Gotay C.C., Banner R.O., DeCambra H., Hammond O.W., et al. Participatory research in a native Hawaiian Community. Cancer. 78:1996;1582-1586.
41. Farley J.H., Hines J.F., Taylor R.R., Carlson J.W., Parker M.F., Kost E.R., et al. Equal care ensures equal survival for African-American women with cervical carcinoma. Cancer. 91:2001;869-873.